Acumen Wealth Advisors’s Labcorp LH Stock Holding History

Acumen Wealth Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-92	Closed	-$23.1K	–	522
2025 Q4	$23.1K	Buy	+92	New	+$24.4K	0.01%	201

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Acumen Wealth Advisors's LH Position: Q1 2026 in Review

Acumen Wealth Advisors sold out of Labcorp (LH) in Q1 2026, closing a stake of 92 shares — an estimated $23.1K sold.

Acumen Wealth Advisors first reported a position in LH in Q4 2025 and held it in 1 quarter. The position peaked at $23.1K in Q4 2025. 1,035 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Acumen Wealth Advisors reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
Acumen Wealth Advisors sold 92 Labcorp shares in Q1 2026, an estimated $23.1K.
Acumen Wealth Advisors first reported a position in Labcorp in Q4 2025 and held it in 1 quarter.
Acumen Wealth Advisors's Labcorp position peaked at $23.1K in Q4 2025.
1,035 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Acumen Wealth Advisors's 13F filing for Q1 2026, filed 13 May 2026.